Canada struggles with chronic pain care, affecting nearly eight million Canadians and costing over $43 billion annually, about chronic pain.
Canada health funding in the 2026 budget adds $57.4 billion to the Canada Health Transfer, boosting mental-health, addiction and Indigenous care programs.
AI and new strategies are helping combat rising antibiotic resistance by analyzing genetic data to track superbugs and develop novel treatments.
Canada's therapy innovations face patient access hurdles, as a gap between scientific breakthroughs and healthcare coverage persists.
Physicians get a new networking platform to maintain connections with colleagues across hospitals and organizations easily.
Tirzepatide reduces asthma flare-up risk in diabetes patients, according to a study comparing it with semaglutide.
Healthcare leaders say shifting from a perfection mindset to a learning culture reduces fear of errors and promotes steady improvement in health…
The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on whether to grant approval…
FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.
The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.